IMM Ann: 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial - 25th May 2023, 8:19am

annb0t

annb0t

Top 20
IMM Ann: 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial
Price Sensitive: Y
Date: 25th May 2023, 8:19am

>>> Read announcement: Google: IMM Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IMM Ann: Webcast slides for new Efti clinical data in 1st line NSCLC - 23rd Oct 2023, 7:48am
Replies
0
Views
60
annb0t
annb0t
annb0t
IMM Ann: Immutep receives positive scientific advice from EMA - 1st Aug 2023, 12:10pm
Replies
0
Views
75
annb0t
annb0t
annb0t
IMM Ann: 1st Patient Dosed in Phase 2 Soft Tissue Sarcoma Trial - 28th Jul 2023, 8:50am
Replies
0
Views
95
annb0t
annb0t
annb0t
IMM Ann: Change in substantial holding - 1st Jun 2023, 8:22am
Replies
0
Views
88
annb0t
annb0t
annb0t
IMM Ann: Promising New Data in 1st line NSCLC from INSIGHT-003 Trial - 24th May 2023, 9:01am
Replies
0
Views
93
annb0t
annb0t
Top Bottom